Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Schedule of Segment Information (Details)

v3.19.3.a.u2
Segment Reporting - Schedule of Segment Information (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Net revenues - External $ 3,885,977 $ 5,039,112 $ 13,137,816 $ 9,932,989  
(Loss) income from continuing operations before income taxes: (12,127,692) 97,356,081 (38,340,063) (3,965,722)  
Depreciation and amortization 199,996 152,825 609,818 804,074  
Capital expenditures 7,086 103,387 50,801 103,387  
Total assets 16,574,065   16,574,065   $ 14,199,300
Hospital Operations [Member]          
Net revenues - External 3,920,608 5,021,543 13,081,647 9,755,099  
(Loss) income from continuing operations before income taxes: (1,769,400) (1,294,581) (8,946,720) (3,998,943)  
Depreciation and amortization 182,832 39,669 532,979 177,386  
Capital expenditures 7,086 103,387 50,801 103,387  
Total assets 16,831,443   16,831,443   13,568,933
Clinical Laboratory Operations [Member]          
Net revenues - External (34,631) 17,569 56,169 177,890  
(Loss) income from continuing operations before income taxes: (295,908) (547,041) (701,466) (1,765,395)  
Depreciation and amortization 10,036 112,908 69,381 625,877  
Capital expenditures  
Total assets 356,854   356,854   271,426
Corporate [Member]          
(Loss) income from continuing operations before income taxes: (640,044) (973,953) (2,626,953) (3,156,646)  
Depreciation and amortization 7,128 248 7,458 811  
Total assets 1,821,952   1,821,952   2,707,416
Other Income (Expense), Net [Member]          
(Loss) income from continuing operations before income taxes: (9,422,340) $ 100,171,656 (26,064,924) $ 4,955,262  
Assets of AMSG And HTS Classified as Held for Sale [Member]          
Total assets 373,121   373,121   152,171
Eliminations [Member]          
Total assets $ (2,809,305)   $ (2,809,305)   $ (2,500,646)